| 产品名称： | 650E2-2B12, CMCC #10121 (IVI 10083) |
|---|---|
| 商品货号： | TS212809 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Tissue： | spleen |
| Cell Type： | hybridoma: B lymphocyte; somatic cell hybri |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Age： | adult |
| Strain： | BALB/c |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Tumorigenic： | Yes |
| Effects： | Yes, BALB/c and (C57BL/6 X BALB/c)F1 mice |
| Complete Growth Medium： | Depositors culture medium: Modified MA plus 10% fetal bovine serum. |
| Culture Conditions： | Temperature: 37.0°C |
| Isotype： | IgG1 |
| Name of Depositor： | Cetus Corp. |
| U.S. Patent Number： | |
| References： | Ring DB, et al. Monoclonal anti-human breast cancer antibodies. US Patent 5,629,197 dated May 13 1997 Ring DB. Antigen-binding sites of antibody molecules specific for cancer antigens. US Patent 6,054,561 dated Apr 25 2000 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | 650E2-2B12, CMCC #10121 (IVI 10083) |
|---|---|
| 商品货号： | TS212809 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Tissue： | spleen |
| Cell Type： | hybridoma: B lymphocyte; somatic cell hybri |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Age： | adult |
| Strain： | BALB/c |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Tumorigenic： | Yes |
| Effects： | Yes, BALB/c and (C57BL/6 X BALB/c)F1 mice |
| Complete Growth Medium： | Depositors culture medium: Modified MA plus 10% fetal bovine serum. |
| Culture Conditions： | Temperature: 37.0°C |
| Isotype： | IgG1 |
| Name of Depositor： | Cetus Corp. |
| U.S. Patent Number： | |
| References： | Ring DB, et al. Monoclonal anti-human breast cancer antibodies. US Patent 5,629,197 dated May 13 1997 Ring DB. Antigen-binding sites of antibody molecules specific for cancer antigens. US Patent 6,054,561 dated Apr 25 2000 |
